Tuesday, November 24, 2020

Pfizer (PFE) Begins Phase III Study on Hemophilia Candidate

Many companies are developing gene therapy products to treat severe hemophilia A. BioMarin Pharmaceutical BMRN has an investigational gene ...
http://dlvr.it/RmMbth
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...